Epigral Ltd. Financials: Quarterly Results
Revenue
589.1
Cr.
PAT
51.52
Cr.
EBITDA
91.79
Cr.
Epigral Ltd. Q2FY26 Financial Metrics
| Indicator | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 587.36 | 606.54 | 627.63 | 645.24 | 626.06 |
| Total Income From Operations (Cr.) | 587.36 | 606.54 | 627.63 | 645.24 | 626.06 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 91.79 | 130.10 | 142.83 | 153.46 | 151.73 |
| P/L Before Exceptional Items & Tax (Cr.) | 69.95 | 106.73 | 131.06 | 153.53 | 124.41 |
| P/L After Tax from Ordinary Activities (Cr.) | 51.52 | 160.41 | 86.62 | 103.54 | 80.53 |
| Net Profit/Loss For the Period (Cr.) | 51.52 | 160.41 | 86.62 | 103.54 | 80.53 |
| Basic EPS | 11.87 | 37.25 | 20.14 | 24.25 | 19.57 |
FAQs
Epigral Ltd. announced its quarterly results for Q2 FY2026 on November 10, 2025.
In Q2 FY2026, Epigral Ltd. are as follows:
Revenue: ₹589.1 crore
Net Profit: ₹51.52 crore.
For Q2 FY2026, Epigral Ltd. posted ₹589.1 crore in revenue and ₹51.52 crore in net profit.
Past quarterly results for Epigral Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.